Registered Zambia · ZAMRA

Eliminate Liquid

Abamectin 5 mg/ml

What it does

Abamectin is a medication used to treat certain parasitic infections.

Commonly used for: parasitic infections, scabies, river blindness (onchocerciasis)

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.

Sourcing - Kenya only

Registration & product details

Registration no.
-
Registration date
-
Expiry date
-
Status
Registered/Compliant
Active ingredient
Abamectin 5 mg/ml
Strength
5 mg/ml
Pack size
-
Therapeutic class
-
Manufacturer / MAH
Virbac
Applicant / LTR
Virbac RSA (Pty) Ltd
Country of origin
South Africa
Manufacturer location
38 Landmarks Ave, Samrand Business Park, Centurion, 0157, South Africa

Source: Zambia Medicines Regulatory Authority · fetched 2026-03-12 00:01:13 · updated 2026-09-28 03:32:25

Disclaimer: This information is sourced from Zambia Medicines Regulatory Authority (Zambia). Always consult a qualified healthcare professional before using any medication.

About this medicine

Abamectin is a medication used to treat certain parasitic infections.

What it treats

  • parasitic infections
  • scabies
  • river blindness (onchocerciasis)

How it works

Abamectin works by paralyzing and killing certain parasites, helping to eliminate the infection.

Who it's for

This medication is suitable for individuals diagnosed with specific parasitic infections.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: abamectin

BNF-referenced

Abamectin is a macrocyclic lactone insecticide and acaricide used primarily in agriculture for the control of a variety of pests. It is effective against certain nematodes and insects, acting through neurotoxic mechanisms that lead to paralysis and death of the target organisms. Abamectin is derived from the fermentation of the soil bacterium Streptomyces avermitilis.

Indications

  • Control of agricultural pests
  • Management of certain nematode infections

Dosage

Children: Refer to specific product guidelines for dosing.

Adults: Refer to specific product guidelines for dosing.

Mechanism of action

Abamectin works by stimulating the release of gamma-aminobutyric acid (GABA), an inhibitory neurotransmitter in the nervous system of invertebrates. This action leads to increased neuronal excitability, causing paralysis and death of the pests.

Pharmacodynamics

Abamectin exhibits potent insecticidal and acaricidal activity by disrupting neurological function in target pests. The increased GABA release inhibits normal nerve impulse transmission, resulting in paralysis. Its effectiveness can vary based on the pest species and environmental conditions.

Pharmacokinetics

The pharmacokinetics of abamectin involve absorption through the cuticle and gut of the target organisms. It has a relatively low systemic toxicity to mammals due to its limited ability to cross the blood-brain barrier. The compound is metabolized primarily in the liver and excreted in the feces, with a variable half-life depending on the species and conditions.

Pregnancy

There is limited information regarding the safety of abamectin in pregnancy. Caution is advised.

Breast-feeding

It is not known whether abamectin is excreted in human milk. Caution is advised.

Storage

Store in a cool, dry place, away from direct sunlight and out of reach of children.

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

Molecular reference: abamectin

PubChem CID 9920327

Molecular formula: C95H142O28

Mechanism of action

Insecticide and acaricide with contact and stomach action. ... Acts by stimulating the release of gamma-aminobutyric acid, an inhibitory neurotransmitter, thus causing paralysis.

Source: PubChem (NCBI) · pathways from PathBank, Reactome, WikiPathways & PharmGKB.

This drug in other countries

The same active ingredient registered across other registries we cover - including different brands.